Trump tariffs live updates: China strikes back as stocks slide after worst day since 2020 Countries seeking to sell goods to ...
1d
News Medical on MSNGut bacteria may reduce the effectiveness of common medicationsA new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target ...
Caregivers are nurses without licenses, case managers without credentials, therapists without degrees, all while being ...
1d
News-Medical.Net on MSNNew structural and mechanistic understanding for cancer drug designA University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...
A class action lawsuit was filed against Walgreens Boots Alliance (WBA) by Levi & Korsinsky on January 30, 2025. The plaintiffs ...
As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...
EQS-News: SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
EQS-News: SynBiotic SE / Key word (s): Product Launch SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time 01.04.2025 / 15:13 CET/CEST The issuer is solely ...
An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.
The death toll in Myanmar has surpassed 3,000, with more than 4,500 people injured, according to state television MRTV. Yet ...
MIAMI — Hundreds of people swept up in the Trump administration’s crackdown on immigration are being kept at an overcrowded ...
Apr. 3, 2025 — Parkinson's doesn't just affect movement and the brain -- it may also impact the heart, according to new research. Scientists suggest that targeting a key protein outside of the ...
Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results